Related references
Note: Only part of the references are listed.Adenylyl Cyclase-Associated Protein 1 Is a Receptor for Human Resistin and Mediates Inflammatory Actions of Human Monocytes
Sahmin Lee et al.
CELL METABOLISM (2014)
microRNA in the development of diabetic complications
Aaron D. McClelland et al.
CLINICAL SCIENCE (2014)
Hepatocyte Growth Factor/c-Met Signaling Is Required for β-Cell Regeneration
Juan Carlos Alvarez-Perez et al.
DIABETES (2014)
Exosomes provide a protective and enriched source of miRNA for biomarker profiling compared to intracellular and cell-free blood
Lesley Cheng et al.
JOURNAL OF EXTRACELLULAR VESICLES (2014)
Dysregulated miR-155 Expression in Peripheral Blood Mononuclear Cells from Patients with Type 2 Diabetes
N. E. Corral-Fernandez et al.
EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES (2013)
Association of MicroRNA-146a with Autoimmune Diseases
Wang-Dong Xu et al.
INFLAMMATION (2012)
Impact of serum storage conditions on microRNA stability
S. Grasedieck et al.
LEUKEMIA (2012)
Hematopoietic miR155 Deficiency Enhances Atherosclerosis and Decreases Plaque Stability in Hyperlipidemic Mice
Marjo M. P. C. Donners et al.
PLOS ONE (2012)
Cytokinome Profile of Patients with Type 2 Diabetes and/or Chronic Hepatitis C Infection
Susan Costantini et al.
PLOS ONE (2012)
Repressed induction of interferon-related microRNAs miR-146a and miR-155 in peripheral blood mononuclear cells infected with HCV genotype 4
Nada El-Ekiaby et al.
FEBS OPEN BIO (2012)
Significance of serum microRNAs in pre-diabetes and newly diagnosed type 2 diabetes: a clinical study
Lei Kong et al.
ACTA DIABETOLOGICA (2011)
miR-146a is a significant brake on autoimmunity, myeloproliferation, and cancer in mice
Mark P. Boldin et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2011)
Impaired miR-146a expression links subclinical inflammation and insulin resistance in Type 2 diabetes
M. Balasubramanyam et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2011)
The Multi-Level Action of Fatty Acids on Adiponectin Production by Fat Cells
Shakun Karki et al.
PLOS ONE (2011)
MicroRNA-155 Promotes Autoimmune Inflammation by Enhancing Inflammatory T Cell Development
Ryan M. O'Connell et al.
IMMUNITY (2010)
Differential Regulation of Interleukin-1 Receptor-associated Kinase-1 (IRAK-1) and IRAK-2 by MicroRNA-146a and NF-κB in Stressed Human Astroglial Cells and in Alzheimer Disease
Jian Guo Cui et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
The IKK Complex, a Central Regulator of NF-kappa B Activation
Alain Israel
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2010)
Inflammation, heat shock proteins, and type 2 diabetes
Philip L. Hooper et al.
CELL STRESS & CHAPERONES (2009)
Role and therapeutic potential of microRNAs in diabetes
I. G. M. Kolfschoten et al.
DIABETES OBESITY & METABOLISM (2009)
miR-146a Is Critical for Endotoxin-induced Tolerance IMPLICATION IN INNATE IMMUNITY
Md A. Nahid et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
MicroRNAs: Novel Regulators During the Immune Response
Yujing Bi et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2009)
Oxidized LDL impair adipocyte response to insulin by activating serine/threonine kinases
Beatrice Scazzocchio et al.
JOURNAL OF LIPID RESEARCH (2009)
Micro-RNA abundance and stability in human brain: Specific alterations in Alzheimer's disease temporal lobe neocortex
Prerna Sethi et al.
NEUROSCIENCE LETTERS (2009)
Regulation of endothelial cell proliferation by primary monocytes
Shai Y. Schubert et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2008)
The hepatocyte growth factor/c-Met signaling pathway as a therapeutic target to inhibit angiogenesis
Weon-Kyoo You et al.
BMB REPORTS (2008)
Role of microRNAs in vascular diseases, inflammation, and angiogenesis
Carmen Urbich et al.
CARDIOVASCULAR RESEARCH (2008)
Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases
Xi Chen et al.
CELL RESEARCH (2008)
Adipose tissue dysfunction in obesity, diabetes, and vascular diseases
Gideon R. Hajer et al.
EUROPEAN HEART JOURNAL (2008)
Rapid changes in microRNA-146a expression negatively regulate the IL-1β-induced inflammatory response in hunan lung alveolar epithelial cells
Mark M. Perry et al.
JOURNAL OF IMMUNOLOGY (2008)
Circulating microRNAs as stable blood-based markers for cancer detection
Patrick S. Mitchell et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
MicroRNA-155 is induced during the macrophage inflammatory response
Ryan M. O'Connell et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Human Resistin Is a Systemic Immune-Derived Proinflammatory Cytokine Targeting both Leukocytes and Adipocytes
Ivan Nagaev et al.
PLOS ONE (2006)
Hepatocyte growth factor secreted by cultured adipocytes promotes tube formation of vascular endothelial cells in vitro
A. Saiki et al.
INTERNATIONAL JOURNAL OF OBESITY (2006)
Chemokines and incident coronary heart disease -: Results from the MONICA/KORA Augsburg case-cohort study, 1984-2002
Christian Herder et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2006)
NF-κB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses
Konstantin D. Taganov et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Myosin motor Myo1c and its receptor NEMO/IKK-γ promote TNF-α-induced serine307 phosphorylation of IRS-1
Yoshitaka Nakamori et al.
JOURNAL OF CELL BIOLOGY (2006)
Clinical significance of circulating hepatocyte growth factor, a new risk marker of carotid atherosclerosis in patients with Type 2 diabetes
K. Satani et al.
DIABETIC MEDICINE (2006)
The potential role of resistin in atherogenesis
MS Burnett et al.
ATHEROSCLEROSIS (2005)
Inflammation and activated innate immunity in the pathogenesis of type 2 diabetes
JC Pickup
DIABETES CARE (2004)
Inflammatory markers and risk of developing type 2 diabetes in women
FB Hu et al.
DIABETES (2004)
Inflammatory cytokines and the risk to develop type 2 diabetes -: Results of the prospective population-based European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam study
J Spranger et al.
DIABETES (2003)